Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
24 Leser
Artikel bewerten:
(0)

Venipuncture Needle and Syringes Market - Global Forecast & Analysis to 2021 - Lack of Skilled Professionals is a Key Market Challenge - Research and Markets

DUBLIN, Mar. 21, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Venipuncture Procedure Analysis by Success Rate, Vein Type, End Users - Global Forecast to 2021" report to their offering.

Research and Markets Logo

The venipuncture needle and syringes market is projected to reach USD 1,044.6 Million by 2021 from USD 790.8 Million in 2016, at a CAGR of 5.7% during the forecast period. The U.S. total venipuncture procedure volume contributed the largest share in 2016 and poised to grow at a CAGR of 1.8%.

Factors such as aging population, cardiovascular disease death rate, pediatric population, chronic diseases conditions will make venipuncture difficult. It becomes difficult for patients with chronic diseases like diabetes, cancer, and cardiovascular conditions; thus, the increasing incidence of these diseases will increase the overall difficulty of the procedure. The lack of skilled professionals will also make venipuncture becomes difficult to perform.

Based on vein type, the venipuncture procedures of Canada are classified into median cubital vein, cephalic vein, basilic vein, and other veins. The other veins segment includes great saphenous, femoral, scalp, subclavian, and metacarpal veins. The procedures in each vein type are further divided into total venipuncture procedures and successful venipuncture procedures. In 2016, the median cubital vein segment is expected to account for the largest share of the venipuncture procedures.

Based on end user, the venipuncture procedures of France are classified into hospitals, diagnostic laboratories, physician office laboratories, and others. The others segment includes home care, long-term acute care, and nursing homes. The hospitals segment is accounted for the largest share of the venipuncture procedures in 2016.

On the basis of vein type, the U.K. venipuncture procedures are classified into median cubital vein, cephalic vein, basilic vein, and other veins. The other veins segment includes great saphenous, femoral, scalp, subclavian, and metacarpal veins. In 2016, the median cubital vein segment is expected to account for the largest share of the venipuncture procedures.

Based on countries, the U.S. venipuncture procedures is expected to account for the largest share of the venipuncture procedures in 2016. Followed by the U.K., Germany, Canada, France, Canada, Spain, Italy, Benelux, Nordic Countries, Australia, Switzerland, and Austria.

Key Topics Covered:

1 Introduction

2 Market Segmentation

3 Research Methodology

4 Venipuncture Needles and Syringes Market, By Region

5 Venipuncture Procedures: Market Overview

6 Venipuncture Procedures: U.S

7 Venipuncture Procedures: U.K

8 Venipuncture Procedures: Germany

9 Venipuncture Procedures: Canada

10 Venipuncture Procedures: France

11 Venipuncture Procedures: Italy

12 Venipuncture Procedures: Switzerland

13 Venipuncture Procedures: Austria

14 Venipuncture Procedures: Spain

15 Venipuncture Procedures: Nordic Countries

16 Venipuncture Procedures: Australia

17 Venipuncture Procedures: Benelux

For more information about this report visit http://www.researchandmarkets.com/research/cnwvnw/venipuncture

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.